AAAAAA

   
Results: 1-7 |
Results: 7
Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine
Authors: Rusconi, S Catamancio, SL Citterio, P Bulgheroni, E Kurtagic, S Galazzi, M Croce, F Moroni, M Galli, M
Citation: S. Rusconi et al., Virological response in multidrug-experienced HIV-1-infected subjects failing highly active combination regimens after shifting from lamivudine to didanosine, ANTIVIR TH, 6(1), 2001, pp. 41-46
In vitro evolution of the human immunodeficiency virus type 1 Gag-proteaseregion and maintenance of reverse transcriptase resistance following prolonged drug exposure
Authors: Catamancio, SL De Pasquale, MP Citterio, P Kurtagic, S Galli, M Rusconi, S
Citation: Sl. Catamancio et al., In vitro evolution of the human immunodeficiency virus type 1 Gag-proteaseregion and maintenance of reverse transcriptase resistance following prolonged drug exposure, J CLIN MICR, 39(3), 2001, pp. 1124-1129
A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215
Authors: Rusconi, S Catamancio, SL Sheridan, F Parker, D
Citation: S. Rusconi et al., A genotypic analysis of patients receiving Zidovudine with either Lamivudine, Didanosine or Zalcitabine dual therapy using the LiPA point mutation assay to detect genotypic variation at codons 41, 69, 70, 74, 184 and 215, J CLIN VIRO, 19(3), 2000, pp. 135-142
In vitro inhibition of HIV-1 by Met-SDF-1 beta alone or in combination with antiretroviral drugs
Authors: Rusconi, S Merill, DP Catamancio, SL Citterio, P Bulgheroni, E Croce, F Chou, TC Yang, OO Herrmann, SH Galli, M Hirsch, MS
Citation: S. Rusconi et al., In vitro inhibition of HIV-1 by Met-SDF-1 beta alone or in combination with antiretroviral drugs, ANTIVIR TH, 5(3), 2000, pp. 199-204
Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase
Authors: Bonfanti, P Faggion, I Catamancio, SL Violin, M Balotta, C Rusconi, S
Citation: P. Bonfanti et al., Response to antiretroviral therapy in a patient with an uncommon codon 69 insertion in the human immunodeficiency virus type 1 reverse transcriptase, ANTIM AG CH, 44(6), 2000, pp. 1767-1768
Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: In vitro studies of mixed virus infections
Authors: Rusconi, S Catamancio, SL Citterio, P Bulgheroni, E Croce, F Herrmann, SH Offord, RE Galli, M Hirsch, MS
Citation: S. Rusconi et al., Combination of CCR5 and CXCR4 inhibitors in therapy of human immunodeficiency virus type 1 infection: In vitro studies of mixed virus infections, J VIROLOGY, 74(19), 2000, pp. 9328-9332
Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure
Authors: Rusconi, S De Pasquale, MP Milazzo, L Kurtagic, S Bulgheroni, E Citterio, P Galazzi, M Catamancio, SL Galli, M
Citation: S. Rusconi et al., Loss of lamivudine resistance in a zidovudine and lamivudine dual-resistant HIV-1 isolate after discontinuation of in vitro lamivudine drug pressure, ANTIVIR TH, 3(4), 1998, pp. 203-207
Risultati: 1-7 |